-
EP3753937
European procedure
Extract from the Register of European Patents
EP About this file: EP3753937
| EP3753937 - ATR INHIBITOR AND APPLICATION THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 08.12.2023 Database last updated on 03.09.2024 | |
| Former | Grant of patent is intended Status updated on 09.08.2023 | ||
| Former | Examination is in progress Status updated on 02.12.2022 | ||
| Former | Request for examination was made Status updated on 20.11.2020 | ||
| Former | The international publication has been made Status updated on 17.08.2019 | Most recent event Tooltip | 12.01.2024 | Deletion: Renewal fee paid | Applicant(s) | For all designated states Wuxi Biocity Biopharmaceutics Co., Ltd. Room 315, Meiliang Road No. 88 Mashan, Binhu District Wuxi, Jiangsu 214000 / CN | [2022/25] |
| Former [2020/52] | For all designated states SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT COMPANY, LTD. Floor 16, Innovation Building No. 315 Yangtze River Avenue Hi-tech District Shijiazhuang, Hebei 050000 / CN | Inventor(s) | 01 /
QIAN, Wenyuan 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 02 /
WANG, Jian 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 03 /
LI, Jie 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 04 /
LI, Jian 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | 05 /
CHEN, Shuhui 288 Futezhong Road, Pudong New Area Shanghai 200131 / CN | [2020/52] | Representative(s) | Schnappauf, Georg ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2020/52] | Application number, filing date | 19750376.6 | 02.02.2019 | [2020/52] | WO2019CN74578 | Priority number, date | CN201810124494 | 07.02.2018 Original published format: CN201810124494 | CN201811361512 | 15.11.2018 Original published format: CN201811361512 | [2020/52] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019154365 | Date: | 15.08.2019 | Language: | ZH | [2019/33] | Type: | A1 Application with search report | No.: | EP3753937 | Date: | 23.12.2020 | Language: | EN | [2020/52] | Type: | B1 Patent specification | No.: | EP3753937 | Date: | 10.01.2024 | Language: | EN | [2024/02] | Search report(s) | International search report - published on: | CN | 15.08.2019 | (Supplementary) European search report - dispatched on: | EP | 07.06.2021 | Classification | IPC: | C07D471/04, C07D401/14, C07D403/14, A61P35/00, A61K31/437, C07D413/14 | [2021/27] | CPC: |
C07D413/14 (EP,US);
A61K31/5377 (IL);
A61P35/00 (EP,IL,US);
C07D403/14 (IL);
C07D471/04 (EP,IL,US)
|
| Former IPC [2020/52] | C07D471/04, C07D401/14, C07D403/14, A61P35/00, A61K31/437 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/52] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ATR-INHIBITOR UND ANWENDUNG DAVON | [2020/52] | English: | ATR INHIBITOR AND APPLICATION THEREOF | [2020/52] | French: | INHIBITEUR D'ATR ET SON APPLICATION | [2020/52] | Entry into regional phase | 04.09.2020 | Translation filed | 04.09.2020 | National basic fee paid | 04.09.2020 | Search fee paid | 04.09.2020 | Designation fee(s) paid | 04.09.2020 | Examination fee paid | Examination procedure | 04.09.2020 | Examination requested [2020/52] | 28.12.2021 | Amendment by applicant (claims and/or description) | 02.12.2022 | Despatch of a communication from the examining division (Time limit: M04) | 11.04.2023 | Reply to a communication from the examining division | 10.08.2023 | Communication of intention to grant the patent | 05.12.2023 | Fee for grant paid | 05.12.2023 | Fee for publishing/printing paid | 05.12.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 17.02.2021 | Renewal fee patent year 03 | 25.01.2022 | Renewal fee patent year 04 | 28.01.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2009093981 (S BIO PTE LTD [SG], et al); | [I]WO2010073034 (ASTRAZENECA AB [SE], et al); | [ID]WO2011154737 (ASTRAZENECA AB [SE], et al); | [IA]WO2014140644 (FUNDACIÓN CT NAC DE INVESTIGACIONES ONCOLÓGICAS CARLOS III [ES]); | [E]WO2019050889 (BLUEVALLEY PHARMACEUTICAL LLC [US]) | International search | [X]WO2009093981 (S BIO PTE LTD [SG], et al); | [A]CN103068391 (ASTRAZENECA AB); | [E]WO2019050889 (BLUEVALLEY PHARMACEUTICAL LLC [US]) | by applicant | WO2011154737 |